Our clinical and research experts—including cerebrovascular neurosurgeons, vascular neurologists, pediatric neurosurgeons, and neuro-radiologists—utilize advanced imaging technology to evaluate patients with moyamoya disease, and determine whether they can be either managed medically or benefit from blood flow restoration surgery. There are several individualized surgical options for each patient using direct, indirect or combined revascularization techniques that bypass the narrowed carotid arteries and/or create a new blood supply to the brain. These techniques include encephaloduroarteriosynangiosis (EDAS) and superficial temporal to middle cerebral artery anastomosis (STA-MCA) bypass. 

In December 2023, we published two articles; one examines the ethnic-associated phenotype variations in moyamoya cerebrovascular outcomes, and highlights the unique features and phenotypes of cases among different ethnicities. The other publication features our current understanding of the disease, as well as research on the associated neuropsychiatric sequelae, such as cognitive impairment, psychiatric disorders, and quality of life.